Generating highly specific antibodies against short peptide epitopes remains challenging, particularly when target sequences are highly conserved across species. Conventional peptide immunization typically relies on carrier proteins to enhance immunogenicity; however, strong immune responses against the carrier can compete with or distract from responses directed toward the intended target epitope. Conigen has developed a unique carrier-free immunization technology designed to overcome these limitations and enable precision antibody generation against challenging peptide targets.
By eliminating conventional carrier proteins, this approach minimizes carrier-induced immune interference and focuses the immune response directly on the target peptide. The platform is particularly valuable for short, highly conserved sequences where immune tolerance and limited epitope availability can make antibody generation difficult. Using this strategy, Conigen has successfully generated highly specific and sensitive antibodies against numerous challenging targets, including conserved epitopes within G protein-coupled receptors (GPCRs) and isoform-specific antibody responses against FGFR4. The resulting antibodies can recognize defined target regions while providing the specificity required to distinguish closely related proteins or homologous sequences.
This carrier-free precision immunization platform expands access to previously difficult antibody targets, such as conserved, high-homology targets like GPCRs. Additionally, it provides a versatile approach for generating epitope-focused, isoform-specific antibodies like FGFR4. The technology can support antibody discovery across biomarker research, diagnostic assay development, therapeutic antibody programs, target validation, and basic biomedical research.
